EyePod

John Kitchens, MD, sits down with Diana Do, MD, to discuss the PHOTON results and their relation to patients with diabetic macular edema in clinical practice.

John Kitchens, MD, sits down with David Brown, MD, to discuss the PULSAR results and their relation to patients with neovascular age-related macular degeneration in clinical practice.  

This PER On Air - Ophthalmology Times podcast examines the new treatment paradigm for patients with geographic atropy, following the introduction of complement-targeting therapies. In this podcast, experts, Dr Cecelia Koetting and Dr Talia Kaden review some of the key highlights from the live satellite symposium, Community Practice Connection™: Mastering the New Treatment Paradigm in Geographic At...

In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment. Faculty: Roger A. Goldberg, MD, MBA Vitreoretinal Specialist Bay Area Retina Associates Volunteer Faculty Californ...

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to learn about the progress in developing a stem cell patch for treating advanced dry age-related macular degeneration. Developed by a team of researchers at USC, the stem cell patch represents a significant advancement in treatment. Dr. Humayun talks about the inspiration behind the patch,...

This podcast features engaging commentary from experts in the clinical management of glaucoma. These experts share information about traditional and newer therapies for glaucoma, including topical drops, sustained drug delivery options, and minimally invasive glaucoma surgery. They discuss safety and efficacy data with an emphasis on appropriate patient selection, as well as key take-home points a...

The role of calendars may be growing more important when managing patients with nAMD and DME. How many weeks can patients go between injections with newer anti-VEGF agents versus older options? How short of an injection interval can patients tolerate before it becomes too much of a burden? In this podcast, Murtaza Adam, MD; Laxmi Devisetty, MD, Hong-Uyen Hua, MD; and Sherrol Reynolds, OD; share in...

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis

Tune in to the first of a new series of Ophthalmology Times EyePod podcasts focusing on innovation in ophthalmology. Throughout this series, we'll be hearing insights from various stakeholders including those in clinical practice, academia, and industry. The overarching message in this podcast is intended to be informational and not promotional. Today, our host Ehsan Sadri, MD, will be in conversa...

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023. 

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

Take a look at a review of the highlights from Ophthalmology Times during the week of January 21, 2024. 

Take a look at a review of the highlights from Ophthalmology Times during the week of January 7, 2024. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023. 

Explore the practical side of femtosecond laser-assisted cataract surgery (FLACS) with Neda Shamie, MD, and Peter J. McDonnell, MD. In this podcast, they discuss real-world experiences, patient choices, and the nuances of integrating FLACS into practice, offering insights into the latest developments in ophthalmology.

In this episode, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss the benefits and challenges of implementing the many options from the premium lens pipeline into practice, emphasizing the importance of customization based on patients' lifestyles and expectations, while also addressing concerns and sharing their positive experiences with the evolving technology in the field.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of December 2, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023. 

Peter J. McDonnell, MD, and Neda Shamie, MD, consider the transformative landscape of cataract surgery, highlighting the impact of small-aperture IOL technology. The conversation delves into its potential benefits, influence on the market, and the evolving role of cataract surgeons in guiding patients through advanced options.

Welcome to this special edition of the Ophthalmology Times ® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast features an international panel of ophthalmologists, including Arshad M. Khanani, MD, MA, FASRS; Carl J. Danzig, MD, FASRS; and Anat Loewenstein, MD, MHA, who will discuss unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) an...

Welcome to this special edition of the Ophthalmology Times ® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast examines how key therapies for treating diabetic macular edema—anti-VEGF agents and corticosteroids—address the underlying pathophysiology of the condition to effectively and safely treat it. In this podcast, 3 ophthalmologists—Fernando Arevalo, MD; Peter Ka...

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of October 1, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of September 24,  2023.